BIOHK (香港国际生物科技论坛展览), the premier biotechnology conference and exhibition in Asia, was established to create a collaborative platform where leaders, innovators, and stakeholders across the biotech ecosystem come together to share insights, explore emerging technologies, and shape the future of biotechnology.
Our participation in BIOHK 2025 reflects our commitment to active collaboration and meaningful knowledge exchange within the industry. By engaging with researchers, healthcare professionals, investors, and strategic partners, we remain closely connected to the latest developments while contributing our perspectives on diagnostic innovation and improving access to healthcare solutions.
Image Source: BioHK
During the conference, our Founder and CEO, Dr Kate Qi, was honoured to speak on how SG Diagnostics’ STRIDE Movement supports smarter and more effective chronic disease management within primary care. Through innovative, accessible, and decentralised solutions, we aim to reach 66.3 million people by 2030 and help reduce healthcare costs by up to 87%.
These conversations and connections made BIOHK a valuable opportunity for us to align with like-minded organisations, strengthen partnerships, and continue advancing solutions that drive better health outcomes across the region.
We would like to thank BIOHK for the opportunity to share our vision and for the many inspiring connections made during the event. We look forward to building on this momentum and continuing to drive innovation and better health outcomes together.
